These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 30048964)

  • 81. BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction.
    Djamali A; Sadowski EA; Muehrer RJ; Reese S; Smavatkul C; Vidyasagar A; Fain SB; Lipscomb RC; Hullett DH; Samaniego-Picota M; Grist TM; Becker BN
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F513-22. PubMed ID: 17062846
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Renal blood oxygenation level-dependent magnetic resonance imaging to measure renal tissue oxygenation: a statement paper and systematic review.
    Pruijm M; Mendichovszky IA; Liss P; Van der Niepen P; Textor SC; Lerman LO; Krediet CTP; Caroli A; Burnier M; Prasad PV
    Nephrol Dial Transplant; 2018 Sep; 33(suppl_2):ii22-ii28. PubMed ID: 30137579
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.
    Sundqvist S; Larson T; Cauliez B; Bauer F; Dumont A; Le Roy F; Hanoy M; Fréguin-Bouilland C; Godin M; Guerrot D
    PLoS One; 2016; 11(8):e0159914. PubMed ID: 27548064
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
    Kanbay M; Siriopol D; Saglam M; Kurt YG; Gok M; Cetinkaya H; Karaman M; Unal HU; Oguz Y; Sari S; Eyileten T; Goldsmith D; Vural A; Veisa G; Covic A; Yilmaz MI
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Beneficial effects of Fu-Zheng-Qu-Zhuo oral liquid combined with standard integrated therapy in patients with chronic kidney disease (stage 3-4): A randomized placebo-controlled clinical trial.
    Li S; Rao XR; Dai XW; Pei K; Wang L; Huo BM; Wang XJ; Kong LX; Zhang NN; Lian FM
    Medicine (Baltimore); 2017 Jul; 96(28):e7448. PubMed ID: 28700482
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of Risk Prediction With the CKD-EPI and MDRD Equations in Non-ST-Segment Elevation Acute Coronary Syndrome.
    Flores-Blanco PJ; López-Cuenca Á; Januzzi JL; Marín F; Sánchez-Martínez M; Quintana-Giner M; Romero-Aniorte AI; Valdés M; Manzano-Fernández S
    Clin Cardiol; 2016 Sep; 39(9):507-15. PubMed ID: 27249221
    [TBL] [Abstract][Full Text] [Related]  

  • 87. High serum adiponectin as a biomarker of renal dysfunction: Results from the KNOW-CKD study.
    Song SH; Oh TR; Choi HS; Kim CS; Ma SK; Oh KH; Ahn C; Kim SW; Bae EH
    Sci Rep; 2020 Mar; 10(1):5598. PubMed ID: 32221363
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Relationship between mortality and speed of eGFR decline in the 3 months prior to dialysis initiation.
    Inaguma D; Murata M; Tanaka A; Shinjo H
    Clin Exp Nephrol; 2017 Feb; 21(1):159-168. PubMed ID: 27084516
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Tanaka K; Watanabe T; Takeuchi A; Ohashi Y; Nitta K; Akizawa T; Matsuo S; Imai E; Makino H; Hishida A;
    Kidney Int; 2017 Jan; 91(1):227-234. PubMed ID: 27884399
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
    Ryom L; Kirk O; Lundgren JD; Reiss P; Pedersen C; De Wit S; Buzunova S; Gasiorowski J; Gatell JM; Mocroft A;
    HIV Med; 2013 Sep; 14(8):503-8. PubMed ID: 23590641
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease.
    Bevc S; Hojs N; Knehtl M; Ekart R; Hojs R
    Aging Male; 2019 Mar; 22(1):62-67. PubMed ID: 29912597
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
    Liu QF; Ye JM; Yu LX; He AL; Sun Q; He DW; Li SS
    J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor.
    Rezk T; Lachmann HJ; Fontana M; Sachchithanantham S; Mahmood S; Petrie A; Whelan CJ; Pinney JH; Foard D; Lane T; Youngstein T; Wechalekar AD; Bass P; Hawkins PN; Gillmore JD
    Kidney Int; 2017 Dec; 92(6):1476-1483. PubMed ID: 28729034
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Renal handling of zinc in chronic kidney disease patients and the role of circulating zinc levels in renal function decline.
    Damianaki K; Lourenco JM; Braconnier P; Ghobril JP; Devuyst O; Burnier M; Lenglet S; Augsburger M; Thomas A; Pruijm M
    Nephrol Dial Transplant; 2020 Jul; 35(7):1163-1170. PubMed ID: 31006015
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Using magnetic resonance diffusion tensor imaging to evaluate renal function changes in diabetic patients with early-stage chronic kidney disease.
    Ye XJ; Cui SH; Song JW; Liu K; Huang XY; Wang L; Zhou YJ; Yan ZH; Wang GB
    Clin Radiol; 2019 Feb; 74(2):116-122. PubMed ID: 30360880
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
    Chen SC; Chang JM; Yeh SM; Su HM; Chen HC
    Am J Hypertens; 2013 Feb; 26(2):243-9. PubMed ID: 23382409
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Long-term fate of renal function after open surgery for juxtarenal and pararenal aortic aneurysm.
    Sugimoto M; Takahashi N; Niimi K; Kodama A; Banno H; Komori K
    J Vasc Surg; 2018 Apr; 67(4):1042-1050. PubMed ID: 28964618
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Functional MRI evaluation of blood oxygen dependent (BOLD) in renal allograft dysfunction: a prospective study.
    Farg HM; El-Diasty T; Ali-El-Dein B; Refaie A; Abou El-Ghar M
    Acta Radiol; 2024 May; 65(5):397-405. PubMed ID: 38146146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.